Prognostic Significance of Survivin Expression in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Report from the International DLBCL Rituximab-CHOP Consortium Program
Title:
Prognostic Significance of Survivin Expression in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Report from the International DLBCL Rituximab-CHOP Consortium Program
Author:
Liu, Zhiyu Xu-Monette, Zijun Y. Cao, Xin Visco, Carlo Tzankov, Alexander Montes-Moreno, Santiago Dybkær, Karen Chiu, April Orazi, Attilio Zu, Youli Bhagat, Govind Richards, Kristy L. Hsi, Eric D. Choi, William W.L. Han van Krieken, J. Huh, Jooryung Ai, Weiyun Ponzoni, Maurilio Ferreri, Andrés J.M. Farnen, John P. Møller, Michael B. Winter, Jane N. Piris, Miguel A. Medeiros, L. Jeffrey Young, Ken H.